SCHEDULE 13G 0001646799 XXXXXXXX LIVE Common stock, par value $0.001 per share 05/19/2025 0001402328 Sunshine Biopharma Inc. 867781700 333 Las Olas Way, CU4 Suite 433, Fort Lauderdale FL 33301 Rule 13d-1(c) Mitchell P. Kopin X1 0.00 505653.00 0.00 505653.00 505653.00 N 9.99 HC IN Daniel B. Asher X1 0.00 505653.00 0.00 505653.00 505653.00 N 9.99 HC IN Intracoastal Capital LLC DE 0.00 505653.00 0.00 505653.00 505653.00 N 9.99 OO Sunshine Biopharma Inc. 333 Las Olas Way, CU4 Suite 433, Fort Lauderdale, FL 33301 This Schedule 13G is being filed on behalf of (i) Mitchell P. Kopin, an individual ("Mr. Kopin"), (ii) Daniel B. Asher, an individual ("Mr. Asher") and (iii) Intracoastal Capital LLC, a Delaware limited liability company ("Intracoastal" and together with Mr. Kopin and Mr. Asher, collectively the "Reporting Persons"). The principal business office of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483. The principal business office of Mr. Asher is 111 W. Jackson Boulevard, Suite 2000, Chicago, Illinois 60604. Mr. Kopin is a citizen of the United States of America. Mr. Asher is a citizen of the United States of America. Intracoastal is a Delaware limited liability company. Y As of the close of business on May 23, 2025, each of the Reporting Persons may have been deemed to have beneficial ownership of 505,653 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal (the "Intracoastal Warrant"), and all such shares of Common Stock represent beneficial ownership of approximately 9.99% of the Common Stock, based on (1) 4,555,945 shares of Common Stock outstanding as of May 15, 2025, as reported by the Issuer, plus (2) 505,653 shares of Common Stock issuable upon exercise of the Intracoastal Warrant. The foregoing excludes 1,920,856 shares of Common Stock issuable upon exercise of the Intracoastal Warrant because the Intracoastal Warrant contains a blocker provision under which the holder thereof does not have the right to exercise the Intracoastal Warrant to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 9.99% of the Common Stock. Without such blocker provision, each of the Reporting Persons may have been deemed to have beneficial ownership of 2,426,509 shares of Common Stock. 9.99% 0 505,653 0 505,653 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Exhibit 1 - Joint Filing Agreement Mitchell P. Kopin /s/ Mitchell P. Kopin 05/23/2025 Daniel B. Asher /s/ Daniel B. Asher 05/23/2025 Intracoastal Capital LLC /s/ Mitchell P. Kopin 05/23/2025